|
Volumn 15, Issue 3, 2001, Pages 277-289
|
Review article: Tegaserod
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLCHOLINE;
CALCITONIN GENE RELATED PEPTIDE;
CISAPRIDE;
CYTOCHROME P450 1A1;
CYTOCHROME P450 2D6;
GUANINE NUCLEOTIDE BINDING PROTEIN;
HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE;
OROSOMUCOID;
SEROTONIN;
SEROTONIN 1 RECEPTOR;
SEROTONIN 2 RECEPTOR;
SEROTONIN 3 RECEPTOR;
SEROTONIN 4 RECEPTOR;
SUBSTANCE P;
TEGASEROD;
VASOACTIVE INTESTINAL POLYPEPTIDE;
CLINICAL TRIAL;
COLON MOTILITY;
CONSTIPATION;
DIARRHEA;
DOG;
DRUG ABSORPTION;
DRUG EFFICACY;
DRUG EXCRETION;
DRUG GLUCURONIDATION;
DRUG SAFETY;
HEART ARRHYTHMIA;
HUMAN;
INTESTINE TRANSIT TIME;
IRRITABLE COLON;
LONG QT SYNDROME;
NONHUMAN;
OVARY CYST;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
REVIEW;
STOMACH EMPTYING;
ABDOMINAL PAIN;
ABSORPTION;
ADMINISTRATION, ORAL;
ANIMALS;
COLONIC DISEASES, FUNCTIONAL;
DIARRHEA;
DOGS;
FEMALE;
GASTROINTESTINAL AGENTS;
GASTROINTESTINAL TRANSIT;
HUMANS;
INDOLES;
MALE;
PATIENT SATISFACTION;
RANDOMIZED CONTROLLED TRIALS;
TREATMENT OUTCOME;
|
EID: 0035123099
PISSN: 02692813
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2036.2001.00925.x Document Type: Review |
Times cited : (194)
|
References (42)
|